Published in Aging and Elder Health Week, December 11th, 2005
"Genotype of HCV is of major importance for the outcome of treatment. The response rate is considerably lower for genotype 1, the predominant genotype in western countries."
M. Lindh and colleagues, Gothenburg University, wrote: "[Our goal was] to develop and evaluate a new, simple method for genotyping of HCV based on real-time PCR and Taqman probes targeting the 5' non-coding region."
"The method was compared with Innolipa on 220 serum samples representing genotypes 1-4, and was applied on a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.